{"nct_id":"NCT03011372","title":"A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2017-04-25","start_date_type":"ACTUAL","primary_completion_date":"2024-10-30","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}